170 related articles for article (PubMed ID: 32982307)
1. Long Noncoding RNA
Pu J; Tan C; Shao Z; Wu X; Zhang Y; Xu Z; Wang J; Tang Q; Wei H
Onco Targets Ther; 2020; 13():9203-9211. PubMed ID: 32982307
[TBL] [Abstract][Full Text] [Related]
2. Tumor-derived extracellular vesicles containing long noncoding RNA PART1 exert oncogenic effect in hepatocellular carcinoma by polarizing macrophages into M2.
Zhou J; Che J; Xu L; Yang W; Zhou W; Zhou C
Dig Liver Dis; 2022 Apr; 54(4):543-553. PubMed ID: 34497040
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA PART1 Exerts Tumor Suppressive Functions in Glioma via Sponging miR-190a-3p and Inactivation of PTEN/AKT Pathway.
Jin Z; Piao L; Sun G; Lv C; Jing Y; Jin R
Onco Targets Ther; 2020; 13():1073-1086. PubMed ID: 32099409
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA PART1 Promotes Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells via miR-149-5p/MAP2K1 Axis.
Zhou C; Wang P; Tu M; Huang Y; Xiong F; Wu Y
Cancer Manag Res; 2020; 12():3771-3782. PubMed ID: 32547213
[TBL] [Abstract][Full Text] [Related]
5. lncRNA NORAD promotes hepatocellular carcinoma progression via regulating miR-144-3p/SEPT2.
Tian Q; Yan X; Yang L; Liu Z; Yuan Z; Shen Z; Zhang Y
Am J Transl Res; 2020; 12(5):2257-2266. PubMed ID: 32509217
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PART1 Inhibits Proliferation and Differentiation of Hep3B Cells by Targeting hsa-miR-3529-3p/FOXC2 Axis.
Weng Z; Peng J; Wu W; Zhang C; Zhao J; Gao H
J Oncol; 2021; 2021():7792223. PubMed ID: 34484336
[TBL] [Abstract][Full Text] [Related]
7. LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis.
Zhu YJ; Jiang DM
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8175-8185. PubMed ID: 31646607
[TBL] [Abstract][Full Text] [Related]
8. SNHG5 functions as competitive RNA with miR-23c to regulate HMGB2 expression in hepatocellular carcinoma.
Li W; Lu Y; Wu Y; Qin Z; Tang Q; Wei H; Wang J; Pu J
Am J Transl Res; 2020; 12(5):2192-2200. PubMed ID: 32509211
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Exosomal LncRNA PART1 in Esophageal Cancer Angiogenesis by Targeting miR-302a-3p/CDC25A Axis.
Ding N; Song X; Yu H; Wang J; Huang L; Zhou Y; He X
Technol Cancer Res Treat; 2023; 22():15330338231184327. PubMed ID: 37386808
[TBL] [Abstract][Full Text] [Related]
10. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
12. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
Zhang ZB; Liu N
Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
[TBL] [Abstract][Full Text] [Related]
14. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
[TBL] [Abstract][Full Text] [Related]
15. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
16. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA circZNF566 promotes hepatocellular carcinoma progression by sponging miR-4738-3p and regulating TDO2 expression.
Li S; Weng J; Song F; Li L; Xiao C; Yang W; Xu J
Cell Death Dis; 2020 Jun; 11(6):452. PubMed ID: 32532962
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA PART1 predicts a poor prognosis and promotes the malignant progression of pancreatic cancer by sponging miR-122.
Hu X; Zhang L; Tian J; Ma J
World J Surg Oncol; 2021 Apr; 19(1):122. PubMed ID: 33865422
[TBL] [Abstract][Full Text] [Related]
19. Role of lncRNA LINC01194 in hepatocellular carcinoma via the miR-655-3p/SMAD family member 5 axis.
Liu Y; Liu J; Cui J; Zhong R; Sun G
Bioengineered; 2022 Jan; 13(1):1115-1125. PubMed ID: 34978464
[TBL] [Abstract][Full Text] [Related]
20. lncRNA PART1, manipulated by transcriptional factor FOXP2, suppresses proliferation and invasion in ESCC by regulating the miR‑18a‑5p/SOX6 signaling axis.
Zhao Y; Zhang Q; Liu H; Wang N; Zhang X; Yang S
Oncol Rep; 2021 Mar; 45(3):1118-1132. PubMed ID: 33432363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
